| Identification | Back Directory | [Name]
3-MERCAPTO-3-METHYL-BUTYRYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2 | [CAS]
73168-24-8 | [Synonyms]
AVPX
Aavp
Avpa
Cgp 25838
sk&f100273
MANNING COMPOUND
(d(CH2)51,Tyr(Me)2,A
[d(CH2)5,Tyr(Me)2]AVP
[PMP1,TYR(ME)2]-ARG8-VASOPRESSIN
[PMP1,TYR(OME)2,ARG8] VASOPRESSIN
(d(CH?)?1,Tyr(Me)2,Arg?)-Vasopressin
[d(CH2)5,Tyr(Me)2]Arginine vasopressin
(D(CH2)(5/1),TYR(ME)2,ARG8)-VASOPRESSIN
(DEAMINO-PEN1,TYR(ME)2,ARG8)-VASOPRESSIN
[DEAMINO-PEN1, O-ME-TYR2,ARG8]-VASOPRESSIN
(D(Ch2)5(1)-o-me-Tyr(2)-Arg(8))vasopressin
PMP-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2
[D(CH2)51, TYR(ME)2, VAL4, ARG8]-VASOPRESSIN
(B-mercapto-B,B-cyclopentamethyl-*enepropionyl1,O
(B-MERCAPTO-B,B-CYCLOPENTAMETHYL-*ENEPRO PIONYL1,O-M
vasopressin mercaptocyclohexaneacetic acid, MeTyr-8-L-Arg
PMP-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2, PMP1-CYS6, CYCLIC
[(3-Mercapto-3,3-pentamethylenepropionic acid)1,O-Methyl-Tyr2]AVP
3-MERCAPTO-3-METHYL-BUTYRYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2
3-MERCAPTO-3-METHYLBUTYRYL-TYR[O-METHYL]-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2
[1-MERCAPTOCYCLOHEXYL]ACETYL-TYR[O-METHYL]-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2
(B-MERCAPTO-B,B-CYCLOPENTAMETHYLENEPROPIONYL1,0-ME-TYR2, ARG8)- VASOPRESSIN)
[BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONYL1,O-ME-TYR2,ARG8]-VASOPRESSIN
b-Mercapto-b,b-cyclopentaMethylene-propionyl-Tyr(Me)-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
1-(beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-methyl-Tyr)-argipressin
Argipressin, (beta-mercapto)beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-Tyr(2)-
BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENE-PROPIONYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2
N-[1-Mercapto(1)cyclohexylacetyl]-O-methyl-L-Tyr-L-Phe-L-Gln-L-Asn-L-Cys(1)-L-Pro-L-Arg-Gly-NH2
Arginine vasopressin, beta-mercapto-(beta,beta-cyclopentamethylenepropionic acid)(1)-methyl-Tyr(2)-
(beta-Mercapto-beta,beta-cyclopentamethylene-propionyl(sup 1),o-me-Tyr(sup 2),Arg(sup 8))-vasopressin
1-(beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-o-methyltyrosyl-8-arginine vasopressin
N-[1-Mercapto(1)cyclohexylacetyl]-O-methyl-L-Tyr-L-Phe-L-Glu(NH2)-L-Asp(NH2)-L-Cys(1)-L-Pro-L-Arg-Gly-NH2
Glycinamide, N-[2-(1-mercaptocyclohexyl)acetyl]-O-methyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-arginyl-, cyclic (1→5)-disulfide | [Molecular Formula]
C52H74N14O12S2 | [MDL Number]
MFCD00076747 | [MOL File]
73168-24-8.mol | [Molecular Weight]
1151.36 |
| Chemical Properties | Back Directory | [density ]
1.50±0.1 g/cm3(Predicted) | [RTECS ]
MB7547500 | [storage temp. ]
−20°C | [solubility ]
H2O: soluble1mg/mL, clear, colorless | [form ]
Solid | [pka]
12.85±0.70(Predicted) | [Water Solubility ]
Soluble to 2 mg/ml in water |
| Hazard Information | Back Directory | [Uses]
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin (SKF 100273) is a vasopressin V1 receptor selective antagonist[1]. | [storage]
Store at -20°C | [References]
[1] Arai Y, et al. New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia. J Pharmacol Sci. 2009 Jan;109(1):53-9. DOI:10.1254/jphs.08r17fm |
|
|